Azadine 150mg Injection

Azadine 150 mg Injection contains Azacitidine, an anticancer medicine used in adults to treat myelodysplastic syndromes (MDS) and certain blood cancers such as chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML), especially in patients not eligible for stem cell transplantation. It works by helping control abnormal blood cell growth in the bone marrow, reducing symptoms like infections, fatigue, fever, and bleeding. Azadine is administered under medical supervision, and patients should inform their doctor about any existing lung, liver, kidney, or heart conditions before treatment. Common side effects include low blood counts, infections, fatigue, nausea, vomiting, digestive issues, injection-site reactions, mouth sores, hair loss, and weakness; persistent or severe effects should be reported to a healthcare professional.